Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.
Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.
Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.
About 74 per cent of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.
Pilot, co-pilot killed after passenger jet hits fire truck at LaGuardia airport
Kuwait launches probe into espionage, state security cases
Trump, Iran threaten to escalate conflict with attacks on energy and water facilities
Fuel reservoir in Russia's Primorsk port on fire after drone attack, governor says
Ambulances from Jewish community organisation torched, UK police say
Israeli airstrikes kill four in Gaza, Palestinian officials say
Iran says Hormuz open to all but ‘enemy-linked’ ships
GCC renews condemnation of ongoing Iranian attacks
